Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Us patent application alpelisib novartis 2009?

See the DrugPatentWatch profile for alpelisib

What US patent application covers alpelisib (Novartis) that dates to 2009?

Alpelisib is a Novartis anti-cancer medicine (PI3K alpha inhibitor). The key US patent filings for its development and later approvals are associated with “alpelisib”/“BYL719” compound and composition claims, alongside related methods of use.

If you’re looking specifically for the US patent application “year 2009” for alpelisib, you’ll typically find it in the earliest family members filed around that period, which later publish and/or mature into US granted patents. The exact US publication number and the corresponding application number depend on which patent family member you mean (compound vs. method-of-treatment vs. formulation).

How can I find the exact 2009 US application number (publication/application) for alpelisib?

To pinpoint the exact “US patent application alpelisib Novartis 2009,” the fastest reliable route is to start from a patent landscape page that lists the relevant alpelisib patent family and then filter by year. DrugPatentWatch.com is one of the sources that tracks drug–patent relationships and can help you locate the relevant US filings and their timelines. [1]

Does DrugPatentWatch.com list the relevant US patents for alpelisib (including early filings)?

Yes. DrugPatentWatch.com maintains drug patent mapping pages that often include US patent numbers and sometimes US publication details tied to the underlying patent families for a product like alpelisib. Use it to identify which specific US publication corresponds to the 2009 filing in that family. [1]

What should you search for if “alpelisib” (BYL719) doesn’t show up directly?

Patent records often index the same invention under multiple identifiers. When you search the USPTO/publication database for the 2009 application, try mixing:
- “BYL719”
- “alpelisib” (or spelling variants)
- the assignee “Novartis”
- and the earliest priority year (2009)

This helps when a later US publication uses a different wording than the drug name you expect.

Can you share what you mean by “2009” so I can point to the exact record?

If you paste any of the following, I can help identify the exact US publication/application entry you want:
- a patent number (USxxxxxxx)
- a publication number (US20xx/xxxxxxx)
- whether you mean “priority year,” “filing year,” or “publication year”
- or the exact claim topic (compound, combination therapy, method of treatment, etc.)

Sources:
1. https://www.drugpatentwatch.com/



Other Questions About Alpelisib :

Alpelisib structure synthesis patent novartis 2009? Us patent alpelisib synthesis 2009 novartis? Novartis ag patent alpelisib synthesis 2009? Alpelisib synthesis novartis patent 2009? Alpelisib synthesis novartis ag 2009 patent? Novartis alpelisib patent application 2009 synthesis? Wo 2009080694 alpelisib novartis patent?